Neoadjuvant single-dose trilaciclib prior to combination chemotherapy in patients with early triple-negative breast cancer: Safety, efficacy, and immune correlate data from a phase 2 study
Force, Jeremy Meyer, O'Shaughnessy, Joyce, Wang, Lisa S., Mosalpuria, Kailash, Hurvitz, Sara A., Goel, Shom, Ahn, Sarah, Cao, Subing, Russo, Melissa, Yi, John S., Oyekunle, Taofik, Jacobson, Amanda, Beelen, Andrew Paul, Danso, Michael A.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer
Hurvitz, Sara A., Peddi, Parvin F., Tetef, Merry L., McAndrew, Nicholas Patrick, Master, Aashini K., DiNome, Maggie L., Lee, Minna K, Wang, Lisa S., Spring, Laura, Kivork, Christine, Chauv, James, Bardia, Aditya
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early-stage breast cancer
Hurvitz, Sara A., Wang, Lisa S., Chan, David, Phan, Vu, Lomis, Thomas, McAndrew, Nicholas Patrick, Spring, Laura, Tetef, Merry L., Villa, Deborah, Applebaum, Steven, Chamberlain, Erin, Dakhil, Shaker R., DiCarlo, Brian Anthony, Kim, David D., Kirimis, Evangelia K., Lawler, William E., Master, Aashini K., Kivork, Christine, Chauv, James, Bardia, Aditya
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Abstract OT1-12-05: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer
Hurvitz, Sara, Bardia, Aditya, Tetef, Merry L., McAndrew, Nicholas P., Applebaum, Steven, Master, Aashini K., DiNome, Maggie L., Lee, Minna K., Kirimis, Evangelia, Kim, David D., Wang, Lisa S., Greene, Kyle, Phan, Vu, Abdulla, Nihal, Chan, David, Spring, Laura M., Kivork, Christine, Chauv, James
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Abstract P3-06-03: Trilaciclib induces immune changes within the tumor microenvironment in early-stage triple-negative breast cancer
Danso, Michael, O’Shaughnessy, Joyce, Wang, Lisa S., Mosalpuria, Kailash, Hurvitz, Sara, Goel, Shom, Ahn, Sarah, Cao, Subing, Yi, John S., Oyekunle, Taofik, Jacobson, Amanda, Beelen, Andrew, Force, Jeremy
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract GS2-03: GS2-03 TRIO-US B-12 TALENT: Neoadjuvant trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer
Bardia, Aditya, Hurvitz, Sara, Press, Michael F., Wang, Lisa S., McAndrew, Nicholas P., Chan, David, Phan, Vu, Villa, Deborah, Tetef, Merry L., Chamberlain, Erin, Abdulla, Nihal, Lomis, Thomas, Spring, Laura M., Applebaum, Steven, Dakhil, Shaker, DiCarlo, Brian, Kim, David D., Kirimis, Evangelia, Lawler, William E., Master, Aashini K., McCann, Kelly, Hayashi, Edwin, Kivork, Christine, Chauv, James
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Floret-specific differences in gene expression and support for the hypothesis that tapetal degeneration of Zea mays L. occurs via programmed cell death
David S. Skibbe Xiujuan Wang Lisa A. Borsuk Daniel A. Ashlock Dan Nettleton Patrick S. Schnable
Published in Journal of genetics and genomics (2008)
Get full text
Published in Journal of genetics and genomics (2008)
Journal Article